Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TIA Triage Trial and Evaluation of Vascular-Specific Inflammatory BiomarkerLp-PLA2 as a Stratification Tool for TIA Triage and Stroke Risk

NCT01423201 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01423201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01423201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TIA Triage Trial and Evaluation of Vascular-Specific Inflammatory BiomarkerLp-PLA2 as a Stratification Tool for TIA Triage and Stroke Risk
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
November 2, 2017
Enrollment
262 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident